Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Illumina Unveils New Sequencers; Preliminary Q4 Revenues up 10 Percent

Illumina Unveils New Sequencers; Preliminary Q4 Revenues up 10 Percent

Jan 13, 2020
|
Ben Butkus

This article has been updated from a previous version to update the availability and shipping timelines for Illumina's new sequencers.

SAN FRANCISCO (GenomeWeb) – Illumina President and CEO Francis deSouza on Monday unveiled the company's two newest sequencing platforms, the NextSeq 1000 and NextSeq 2000, at the JP Morgan Healthcare Conference held here.

In addition, deSouza said that Illumina achieved preliminary year-over-year revenue growth of 10 percent in the fourth quarter and 6 percent for full-year 2019.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Maybe Not the Source

The first reported coronavirus cases in Europe and the US might not be related to the subsequent outbreaks in those areas, according to the New York Times.

And Now Machines

According to NPR, there's a growing shortage of machines to run SARS-CoV-2 tests.

Not Making It Clearer

The Wall Street Journal and Kaiser Health News report that antibody testing for SARS-CoV-2 has led to further confusion.

Nature Papers Describe Genome Aggregation Database, Mendelian Randomization Method

In Nature this week: the largest known collection of human genetic variants, and more.

Jun
02
Featured Webinar

The Need for Digital Spatial Profiling for Host-Pathogen Interaction: A York Perspective

Sponsored by
NanoString

Core facilities support a broad range of scientific studies and must constantly integrate new technologies and analysis to underpin their users’ research. Areas for development include higher multiplex capabilities, greater quantification, correlation to other tools, as well as multi-omics. 

Jun
04
Featured Webinar

COVID-19 Testing, Treatment and Future Outlook

Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
09
Featured Webinar

Our Magic DRAGEN: A Sequencing Lab Case Study on Accelerated Bioinformatics

Sponsored by
Illumina

In this webinar, Dr. Charlie Johnson, founder of the Texas A&M AgriLife Genomics and Bioinformatics Service, will share how his team is utilizing Illumina’s DRAGEN informatics platform in its high-throughput agrigenomics research program. 

Jul
15
Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

What's Popular?

In Sequencing

  1. Ginkgo Bioworks Nabs $70M Investment from Illumina, Others to Build Coronavirus NGS Testing

  2. Chan Zuckerberg Initiative Awards $3.8M in Grants for Open-Source Biomedical Software Projects

  3. Oxford Nanopore Technologies Raises £48.4M in Private Financing

  4. GnomAD Consortium Details Range of Human Genetic Variation From Large Dataset

  5. Illumina, Genomic Medicine Sweden to Evaluate Sequencing-Based Leukemia Diagnostics

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.